In conclusion, we have determined COX-2/PGE2 pathway's involvement in the upregulation of MMP-9 in pancreatic cancer, and the restraint of COX-2 inhibitors on MMP-9 expression and cancer cell invasiveness. Here, PTGS2 is linked to pancreatic neoplasm.